Early and Improved TB case detection through the use of GeneXpert technology in Nepal.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

TB/HIV Research Priorities: TB Preventive Therapy.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
Improving diagnosis TB laboratory strengthening.
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
HERD Team. Using Xpert to Reach the Unreached: Mobile Diagnostics Case Finding in Nepal May 2013 – April 2015.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Rapporteur: Dr. Massimo Ghidinelli Facilitator: Dr.Elvira Teodora Wi
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
TB Seminar 2014 Agenda and issues in NTP M&E System ARUN GAUTAM, CHIEF, PME SECTION, NTC.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Country Progress Report Philippines
Nepal TB REACH Project Wave 2 Year 1 (Nov Dec 2012) Year 2 (Jan 2013 – Jun 2014)
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
RNTCP: DOTS Expansion and plans for DOTS-Plus
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
GETTING READY FOR DUAL EMTCT VALIDATION IN THE AMERICAS Adele Schwartz Benzaken.
Unit 10. Monitoring and evaluation
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
PROPOSAL FOR A MODEL MENTAL HEALTH COMMUNITY BASED SERVICE DELIVERY.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Monitoring &Evaluation System in Health Program. Brief overview of NACP Reporting units and quality aspects Data sets Learning/ Analysis of the data sets.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Screening for TB among risk groups in Cambodia Dr. Mao Tan Eang, NTP Director National Center for TB and Leprosy Control, Cambodia TAG Meeting, 9-12 December.
Go to View > Master > Slide Master to edit Place, Month Year GLI and Global Fund focal point Feedback and updates Rachel Bauquerez.
Community involvement in scaling up TB/HIV activities.
Group 1 Presentation: HIV Testing in TB Patients and ART Provision.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
Roundtable. Detection and treatment of TB Andrew Black.
National TB Infection Control Seminar S’celo S. Dlamini Director: Research, Information, Monitoring, Evaluation & Surveillance 12 th of August 2015 Integrating.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TB- HIV Collaborative activities in Romania- may 2006 status
Field Testing of OMNI-gene TB Sputum Optimizer in Malawi
Summary of changes in the RNTCP technical guidelines in
Prisons and TB in Europe
Country Progress Report Cambodia
8-9 August 2009, Bali, Indonesia
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
DR-TB Case-finding and Referral Procedures
5th DEWG meeting Conclusions
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
EXERCISE 11: Computing and Analyzing Program Indicators
Background & rational DEWG meeting 2009
Multi-disease diagnostic integration
Presentation transcript:

Early and Improved TB case detection through the use of GeneXpert technology in Nepal

About IOM International Organization for Migration (IOM) was established in The principal intergovernmental organization in the field of migration. IOM is committed to the principle that humane and orderly migration benefit migrants and societies. Working in more than 150 countries globally, 155 member states, 11 states and numerous international and non-governmental organizations are observers. Established in Nepal in Implementing several large and small projects in the country with the help of more than 400 national and international staff

TB REACH background IOM, in close collaboration with NTP, has successfully implemented TB REACH WAVE 2 Projects in Nepal “Early and improved case detection of TB through the use of GeneXpert technology in Nepal” –Started implementation in Nepal under W2Y1 (Oct Feb. 2013) –Awarded for rollover to year 2 (W2Y2: Mar Apr. 2014) –Recently awarded for Wave4, with several new interventions in the field (Jun 2014 – May 2015 with possibility of no cost extension)

Objectives 1.To increase case finding by increasing sensitivity of laboratory through the use of GeneXpert instruments. 2.To increase TB awareness and referrals through IEC campaign and referral system

1.TB case finding through use of point-of-care GX instruments 2.Increasing TB awareness and referrals among general population. 3.Increasing TB awareness and referrals among PLHA 4.To establish a referral system of smear- negative specimens for GeneXpert testing and specimen of Rifampicin resistant cases for Culture and DST Interventions

INDIA

Populations PopulationSize of the population Evaluation Population 7,444,602 Target Population 63,895 Control Population 2,858,347

Target groups Smear-negative individuals with high suspicion of TB Individuals with high risk of MDR TB –Retreatment (Failure, Relapse and Return after default) –Close contacts of MDR TB patients HIV+ with high suspicion of TB

Test Algorithm Smear not done

Indicators Process indicatorsTargetAchievement Ach. % TB Suspects screened23,42720,22886% SS-ve suspects referred for GX test17,66819,338109% SS-ve suspects Xpert positive5,219 (30) 3,279 (17) 63% HIV+ve referred for Gene X-pert1, % HIV+ve X-pert positive271 (22) 34 (20) 13% Specimen transported from hilly areas 1,6001,10969% Positive among referred cases250 (16) 138 (12) 55%

MTB/RIF Test Results Smear result Total Tests MTB Detected Test Failure RIF-RIF+RIF Indet.Total S-ve19,3383, ,279 (17%) 1,878 (9.7%) S+ve (85%) 38 (5.4%) Direct XP (20%) 12 (6.4%) Total20,2283, ,914 (19%) 1,928 (9.5%)

GX Centre wise achievement

Positivity Rate

Additionality Clear increase in additionality, 25 % in year 1 and 28% in year 2

Achievements All Nine GeneXpert Centres are functioning well in term of equipment and procedures. NTP staff are trained in testing, data recording and reporting on GX process. Over 25 % increase were noted in SS+/B+ cases. Sensitization and advocacy on GeneXpert: increased Interest and enthusiasm to use the technology in Nepal. National policy on GeneXpert is developed. Around 30 % of MTB positive cases are referred from private sectors.

IOM was awarded the Rana Samudra Trophy by NTP

External factors/Challenges Limited culture and DST facility to confirm Rif+ cases and high number of invalid results from culture. Limited working hours at the GeneXpert Centre Laboratories (4 hours) High number of test failure (nearly 10%) Machinery problems (module break down, calibration) Difficulties in assurance of treatment enrolment for all GeneXpert positive cases The current reporting system does not capture the GX+ cases separately

Lesson Learned Referral mechanism and community mobilisation are crucial to increase number of tests. Strict follow up of algorithm (screening by CXR) increases the Xpert test yield. Regular technical support should be provided to GeneXpert centres. Procurement is important, better planning is needed for formalities for releasing Xpert equipments from the costums.

Lesson Learned (Cont) The life of Cartridges is normally short, so to order two shipments per annum will be beneficial. Tempreture for storage to be less than 30 C Tempreture for calibration to be optimal (16 C) Calibration is important and should be done annually. Xpert is helpful in detecting TB cases early and will increase the bacteriological positive cases but may not necessarily increase all form TB cases.

Some other interesting observations!!! Microscopic Centres (MCs) are normally overburdened and there are inadequate infrastructure at the laboratories. Limited opening hours of health service facilities including microscopic centres. There is no adequate communication and interaction between health care providers and patients. Infection Control is also a issue in microscopic centre.

Acknowledgements ! 1.WHO TB REACH/CIDA 2.Dr. Rajendra Pant, NTC Director and his team for providing full supports and guidance to the project 3.All regional and district level NTP officials 4.WHO Nepal TB team, particularly Dr. Giampaolo Mezzabotta 5.Dr. Bhawana Shrestha and her colleagues at GENETUP 6.IOM Nepal Colleagues

Snapshots

stop TB Complete treatment Early Case Detection For more information, please contact: THANK YOU